A key opinion leader explores the integration of bispecifics into MM therapy regimens. This is a video synopsis/summary of a Post Conference Perspectives featuring Rafael Fonseca, MD. When using ...

In this interview, Cerba Research explains how its teams were able to assess clinical response in multiple myeloma (MM) patients that were receiving monoclonal antibodies treatment. In multiple ...

TORONTO -- A substantial proportion of multiple myeloma patients undergoing treatment with bispecific antibodies had sustained remissions when they discontinued therapy before disease progression, ...

After Judith Harding was diagnosed with multiple myeloma in 2009, she decided to retire, sold her condo, dropped out of her PhD program and moved nearer to her family, preparing to "live out my last ...

The initial diagnostic workup should include a history and physical examination, as well as some baseline laboratory studies (Figure 2-1). The initial diagnostic workup should include a history and ...